In multiple sclerosis (MS), neutralizing antibodies are often produced by the immune system in response to some treatments for MS, including Interferon-beta (Avonex, Rebif, Betaseron) and Tysabri.
Neutralizing antibodies may reduce the effectiveness of a particular medication.

